MedTrace Logo

Feasibility of Ayurveda in Patients With Mild-to-Moderate COVID-19: A Community-Based Participatory Research

NCT04716647 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2021-01-20

No results posted yet for this study

Summary

Innovative strategies are required to manage COVID-19 in the communities. Back to Roots community based project was a collaborative, pilot intervention program in British Asian community to assess the efficacy and safety of Ayurveda intervention in relieving symptoms of mild-to-moderate COVID-19.

Conditions

  • Covid19

Interventions

OTHER

Ayurveda

Dosage was used in common range (Ashwagandha: Doses range from 250 mg to 5 g; Giloy: range from 500mg to 1g; Tulsi: 500mg-1g) Dosage were altered based on age, weight and severity of symptoms.

Sponsors & Collaborators

  • University of Warwick

    collaborator OTHER

  • Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University

    collaborator OTHER

  • Aarogyam UK

    lead OTHER

Principal Investigators

  • Neha Sharma · Aarogyam UK

  • Dipa Modi · East Park Medical Centre, NHS trust, Leicester

  • Vishwesh Kulkarni · University of Warwick

  • Abhimanyu Kumar · Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-09
Primary Completion
2020-12-12
Completion
2020-12-18

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04716647 on ClinicalTrials.gov